Public Contracts Scotland · Contract

NP49124 Hepatitis C Medicines

A public procurement published by Clyde Gateway Development Ltd via Public Contracts Scotland.

Public Contracts ScotlandContract
Award value
£35.8m
Tender value
3
Suppliers
7
Awards
2
Notices
Contract
Stage

Overview

Supply of Hepatitis C Medicines to NHS Scotland.

Key details

Source
Public Contracts Scotland
Lifecycle stage
Contract
Status
active
CPV classification
33600000
Currency
GBP
Total award value
Tender value
£35,791,085
First published
1 Dec 2023
Last updated
21 Mar 2024
View the original notice

Awards

7 awards recorded on this procurement.

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Tender noticeNP49124 Hepatitis C Medicines
  2. Award,contractNP49124 Hepatitis C Medicines

All suppliers

Frameworks & programmes

More from Clyde Gateway Development Ltd

FAQs about this procurement

Who is the buyer for "NP49124 Hepatitis C Medicines"?

NP49124 Hepatitis C Medicines is a UK public-sector procurement published by Clyde Gateway Development Ltd via Public Contracts Scotland.

Has "NP49124 Hepatitis C Medicines" been awarded?

Yes — 7 awards are recorded, with a reported total value of £35,791,085. The current lifecycle stage is "Contract".

Which suppliers are involved in "NP49124 Hepatitis C Medicines"?

3 suppliers are linked: Harper Macleod LLP, Blackadders LLP, Shepherd and Wedderburn LLP.

What is "NP49124 Hepatitis C Medicines" worth?

The reported tender value is £35,791,085.

When was "NP49124 Hepatitis C Medicines" published?

It was first published on 1 Dec 2023 and last updated on 21 Mar 2024, across 2 notices.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable